Scarica l'app Stockscreener
5.33
1.11%
-0.06
Dopo l'orario di chiusura:
5.40
0.07
+1.31%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$5.39
Aprire:
$5.4
Volume 24 ore:
1.05M
Relative Volume:
1.93
Capitalizzazione di mercato:
$240.10M
Reddito:
-
Utile/perdita netta:
$-54.19M
Rapporto P/E:
-2.0659
EPS:
-2.58
Flusso di cassa netto:
$-37.34M
1 W Prestazione:
+10.12%
1M Prestazione:
+6.60%
6M Prestazione:
-18.00%
1 anno Prestazione:
+67.08%
Intervallo 1D:
$5.225
$5.48
Intervallo di 1 settimana:
$4.66
$5.68
Portata 52W:
$3.20
$6.78
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Confronta ABEO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
5.33 | 240.10M | 0 | -54.19M | -37.34M | -2.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Abeona Therapeutics Inc (ABEO) looking to reclaim success with recent performance - Sete News
ABEO Shares Experience Surge in Value - knoxdaily.com
Stock Performance Spotlight: Abeona Therapeutics Inc (ABEO) Ends the Day at 5.22, Down by -1.14 - DWinneX
Examining ABEO’s book value per share for the latest quarter - uspostnews.com
Why Invest In Abeona Therapeutics Inc (ABEO) Stock? - Marketing Sentinel
(ABEO) Investment Analysis and Advice - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
Abeona Therapeutics: pz-cel Has Massive Potential For RDEB Patients - Seeking Alpha
Wellington Management Group LLP Acquires Shares of 93,289 Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
Abeona Therapeutics: An Uncertain Pivotal Regulatory Catalyst With Limited Long-Term Upside - Seeking Alpha
Trexquant Investment LP Invests $382,000 in Abeona Therapeutics Inc (NASDAQ:ABEO) - Defense World
FDA Action Alert: Regeneron, Sanofi and Abeona - BioSpace
Abeona Therapeutics: A Buy With Major PDUFA Catalyst On April 29 That Should Send Shares Higher - Seeking Alpha
Abeona Therapeutics Inc. Rings the Nasdaq Stock Market Closing Bell - Nasdaq
Abeona Therapeutics Inc. Rings the Closing Bell - Nasdaq
Stifel initiates Abeona Therapeutics stock with buy, $14 target By Investing.com - Investing.com UK
Krystal Biotech: Some Uncertainty, Some Value (NASDAQ:KRYS) - Seeking Alpha
(ABEO) Technical Data - news.stocktradersdaily.com
Breakeven On The Horizon For Abeona Therapeutics Inc. (NASDAQ:ABEO) - simplywall.st
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona Therapeutics Expands Team with Strategic Stock Grants for Key New Talent - Stock Titan
Abeona Therapeutics CEO sells shares worth $119,500 By Investing.com - Investing.com India
Abeona Therapeutics CEO sells shares worth $119,500 - Investing.com
What is Zacks Small Cap’s Estimate for ABEO Q3 Earnings? - Defense World
Biotech Stocks Facing FDA Decision In April 2025 - RTTNews
What is Zacks Small Cap’s Forecast for ABEO Q1 Earnings? - Defense World
Equities Analysts Set Expectations for ABEO Q1 Earnings - Defense World
Trend Tracker for (ABEO) - news.stocktradersdaily.com
What is HC Wainwright’s Forecast for ABEO Q1 Earnings? - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC Wainwright - Defense World
Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com - Defense World
Abeona Therapeutics: Positive Outlook Amid FDA Hopes - MSN
ABEO: Countdown to PDUFA Date of April 29, 2025… - MSN
ABEO: Countdown to PDUFA Date of April 29, 2025 - Smartkarma
Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript - Insider Monkey
Abeona planning potential US launch of pz-cel to treat RDEB - Epidermolysis Bullosa News
Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo
Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... By GuruFocus - Investing.com Canada
Abeona Therapeutics Reports 2024 Financial Results - TipRanks
Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat - Investing.com India
Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat By Investing.com - Investing.com UK
Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations - MSN
Oppenheimer maintains Abeona Therapeutics Outperform rating - Investing.com India
Abeona Therapeutics® Reports Full Year 2024 Financial - GlobeNewswire
Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
ABEONA THERAPEUTICS INC. SEC 10-K Report - TradingView
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory - Bluefield Daily Telegraph
Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory Update and Commercial Launch Plans - Yahoo
Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and Financial Resilience - GuruFocus
(ABEO) On The My Stocks Page - news.stocktradersdaily.com
Abeona Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
36.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):